Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Primary Objective Dose Escalation Phase: To characterize the prevalence, severity, drug-relatedness and seriousness of adverse events of PledOx in two doses Primary Objective Randomised Treatment Phase: Assess the efficacy of two different doses of PledOx when added to FOLFOX6 chemotherapy as measured by protection from FOLFOX6 toxicity on neutropenia grade 3 and 4 (NCI-CTCAE v4)
Critère d'inclusion
- Metastatic colorectal cancer